Carol BaldwinLocal Journalism Initiative ReporterWakaw RecorderAfter the heavy snowfall, and a drop in temperature across the province, interrupted by a bri ...
The darlings of the weight loss and diabetes spaces, GLP-1 receptor agonists have shown promise against Alzheimer’s in recent studies—with Phase III results expected next year from Novo Nordisk.
At just 20 years old, AlanaBlu Cooley has weathered more storms than many face in a lifetime. Now a mentor and aspiring teacher, she’s transforming a difficult upbringing into a journey marked by ...